Eli Barich

Eli Barich is an Associate at Freestone Grove Partners in New York, NY. In his current role, he is responsible for supporting investment decisions and conducting due diligence across the firm's targeted sectors, leveraging his experience in public equity research and portfolio analysis.

Prior to joining Freestone Grove Partners, Eli served as a Public Equity Senior Associate at OrbiMed, where he focused primarily on healthcare and life sciences equity investments. His tenure at OrbiMed included deep analysis of companies operating in biotechnology, pharmaceuticals, and medical devices, as well as evaluating broader public market opportunities within healthcare.

Eli holds a degree in Economics from the University of Michigan and is known for his analytical acumen in evaluating public equity assets. His expertise in healthcare sectors and rigorous approach to equity analysis have contributed to his reputation as a skilled investment professional in high-growth, innovation-driven industries.